Parker G
School of Psychiatry, University of New South Wales and Black Dog Institute, Sydney, NSW, Australia.
Acta Psychiatr Scand Suppl. 2007(433):21-30. doi: 10.1111/j.1600-0447.2007.00959.x.
To argue that melancholia is a categorically distinct depressive condition, able to be differentiated from other depressive conditions by a neuropathological marker [observable psychomotor disturbance (PMD)] and having a differential response to various antidepressant treatments.
The above statements are addressed by review of a wide body of research, which identified observable PMD as the cardinal marker of melancholia and developed the CORE measure as a strategy for assessing PMD and its severity. Properties of the CORE measure, including reliability, validity and treatment prediction, are overviewed.
A case is made for defining melancholia and a strategy for establishing its probability.
Melancholia is positioned as a categorical entity capable of being circumscribed by its cardinal feature of PMD.
论证忧郁症是一种截然不同的抑郁状态,能够通过一种神经病理学标志物[可观察到的精神运动障碍(PMD)]与其他抑郁状态相区分,并且对各种抗抑郁治疗有不同反应。
通过回顾大量研究来阐述上述观点,这些研究将可观察到的PMD确定为忧郁症的主要标志物,并开发了CORE测量法作为评估PMD及其严重程度的一种策略。概述了CORE测量法的特性,包括可靠性、有效性和治疗预测性。
提出了定义忧郁症的理由以及确定其可能性的策略。
忧郁症被定位为一个能够由其PMD主要特征界定的类别实体。